Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
May/June 2024 Kontos Kommentary The following commentary is produced by Tom Kontos, Chief Economist, ADESA Auctions.
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dive deeper into part
For over three decades, early intervention telephoni
Work-related injuries involving limb or other losses are rare but tragic for any individual and require sensitive care coordination.
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dig into part one of our Annua